← Leaderboards
Scott McNeill Sieburth
State University New York Stony Brook
$1,797,607
Attributed
$1,797,607
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $274.7K · FY2006–09$500K$375K$250K$125K$0
'06
'07
'08
'09
Funding mix
By agency
NIH$1,797,607 · 3
By mechanism
R01$1,358,732 · 2
R21$438,875 · 1
Top collaborators
No co-investigators on record.
Most similar at State University New York Stony Brook
Same institution · by research overlap
- Iwao Ojima$7,814,090
- Raymond James Dattwyler$3,663,501
- Sanford R Simon$451,500
- Joan E Broderick$5,654,762
- James B Bliska$15,447,088
Others in their field
Top investigators on “Protease Inhibitor”
- Constance Ann Benson · University Of California, San Diego$150,461,206
- Robert Turner Schooley · University Of Colorado Denver$48,400,257
- John Damon Chodera · Sloan-Kettering Inst Can Research$40,777,114
- Daniel R Kuritzkes · Brigham And Women'S Hospital$26,572,064
- David Heimbrook · Leidos Biomedical Research, Inc.$26,054,235
- Celia A. Schiffer · Univ Of Massachusetts Med Sch Worcester$24,364,826
Research focus
Protease InhibitorHydrolysisSilanesMetalloendopeptidasesComplexCrystallographyDesignAmino AcidsChymotrypsin-Like EnzymeChymotrypsinAlcohol ConsumptionAspartic EndopeptidasesAsthmaAnalogBenchmarkingAmidesBathingBinding (Molecular Function)Carbonyl GroupCathepsin GApoptosisChymaseAspartic AcidBase
Grant awards (8)
Silanediols as Serine and Threonine Protease Inhibitors$254,596
R01 · FY2009 · GM · contact PI
Silanediols as Serine and Threonine Protease Inhibitors$254,596
R01 · FY2008 · GM · contact PI
Silanediols as Serine and Threonine Protease Inhibitors$254,596
R01 · FY2007 · GM · contact PI
Silanediols as Serine and Threonine Protease Inhibitors$274,700
R01 · FY2006 · GM · contact PI
Anthrax LF Inhibitor Drug Based On Organosilanes$225,750
R21 · FY2003 · AI
Anthrax LF Inhibitor Drug Based On Organosilanes$213,125
R21 · FY2002 · AI
SILANOL INHIBITORS OF METALLOPROTEASE ENZYMES$162,487
R01 · FY2001 · HL
SILANOL INHIBITORS OF METALLOPROTEASE ENZYMES$157,757
R01 · FY2000 · HL